Related Experiment Video

Updated: Feb 3, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

22.4K

In vitro analysis of microRNA-26a in chronic lymphocytic leukemia cells

Jing Li1, Chang-Kui Sun1

  • 1Blood Group Reference Laboratory, Shandong Blood Center, Jinan, Shandong 250014, P.R. China.

International Journal of Molecular Medicine
|October 16, 2018
PubMed

Insights

microRNA-26a-loaded liposomes effectively reduced chronic lymphocytic leukemia cell viability and induced apoptosis. This novel liposomal delivery of miRNA-26a shows therapeutic potential for leukemia and other cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Nanomedicine

Background:

  • Leukemia, particularly chronic lymphocytic leukemia (CLL), remains a significant health challenge.
  • Targeted delivery of therapeutic agents is crucial for improving cancer treatment efficacy.
  • microRNAs (miRNAs) have emerged as potential regulators of cancer development and progression.

Purpose of the Study:

  • To investigate the therapeutic potential of miRNA-26a-loaded liposomes for leukemia treatment.
  • To evaluate the effect of miRNA-26a on the viability and apoptosis of chronic lymphocytic leukemia cells.
  • To assess the impact of miRNA-26a on key target genes involved in leukemia cell proliferation.

Main Methods:

  • Preparation and characterization of miRNA-26a-loaded liposomes.
  • Assessment of cell viability using standard assays.
  • Induction of apoptosis evaluated by flow cytometry and Hoechst 33342 staining.
  • Western blot analysis to determine the expression levels of miRNA-26a target genes (MCL1 and CDK6).

Main Results:

  • miRNA-26a demonstrated a concentration-dependent reduction in chronic lymphocytic leukemia cell viability.
  • Treatment with miRNA-26a-loaded liposomes significantly increased cancer cell apoptosis.
  • Western blot analysis confirmed the downregulation of myeloid cell leukemia 1 (MCL1) and cyclin-dependent kinase 6 (CDK6) expression.
  • Liposomal delivery enhanced the apoptotic effect of miRNA-26a compared to controls.

Conclusions:

  • miRNA-26a exhibits potent apoptosis-inducing and anticancer effects against leukemia cells.
  • Liposomal encapsulation of miRNA-26a provides an effective delivery strategy for leukemia therapy.
  • This miRNA-based liposomal approach holds promise for treating various neoplasms, including lymphomas and acute myeloid leukemia.

More Related Videos

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

11.6K
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

14.2K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.0K
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
11.9K
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
740
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
802
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
366